KEQUNasdaqLaboratory Apparatus & FurnitureFiscal year ends April 30

KEWAUNEE SCIENTIFIC CORP /DE/

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026

$32.10−0.82 (-2.51%)

Close on Oct 19, 2026

Market cap: $93.76M
P/E (TTM): 11.6
Dividend yield: –

Debt

Borrowings on the balance sheet, Jul 31, 2026

Total debt

$18.83M

$5.00M due within a year

Net debt

$10.59M

After $8.25M of cash

Implied interest rate

13.13%

FY2026 interest ÷ average debt

Interest coverage

4.3×

FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Kewaunee Scientific's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Kewaunee Scientific's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-2 split on Jan 7, 1985
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is KEQU.

Revenue growth5.3% · median 3.0%

Gross margin28.6% · median 42.8%

Operating margin5.4% · median -2.8%

Net margin3.0% · median -1.7%

Company	Revenue	Growth
KEQU	$277.22M	+5.3%
MLAB	$249.73M	+3.0%
HURC	$183.24M	-1.9%
INTT	$128.26M	+5.4%
SYPR	$115.11M	-11.5%
RSCF	$1.72M	+25.6%

Company

Next earnings (est.): Dec 9, 2026, during market hours
Exchange: Nasdaq
Industry: Laboratory Apparatus & Furniture
Fiscal year ends: April 30
Held by institutions: 41.4%
Auditor: Forvis Mazars, LLP
SEC CIK: 55529

Advertisement
300 × 250